Prevention

Edmond LaVoie, PhD, describes the properties of prodrug TXA709.

Only 6 countries have gone through pandemic preparedness—here is why that should worry us.

Can increased understanding of the role of the behavioral immune system reveal ways to address issues of bias in society?

Reducing overall antibiotic exposure is likely to have an impact on decreasing antimicrobial resistance.

Candida auris—Are we prepared for another multidrug-resistant pathogen?

This training will empower pharmacists practicing in LTC facilities to develop antimicrobial stewardship programs, improve patient outcomes related to infectious diseases, and facilitate compliance with CMS requirements.

An ingestible smart pill developed by Proteus Digital Health can remind patients with chronic diseases to take their medication.

The Center for Health Security has given us a powerful tool against future biological threats.

ason Gallagher, PharmD, BCPS FCCP, FIDSA, explains why clinicians should be aware of the challenges associated with getting antimicrobial susceptibility testing results.

The decision date for a NDA for a new hepatitis B vaccine, Dynavax’s Heplisav-B, has been delayed, as the FDA asked for more post-marketing study information on the vaccine.

Arjun Srinivasan, MD, discusses how outbreaks can occur in operating rooms.

A team of researchers at Stevens Institute of Technology are working on the development of a rapid, cost-effective diagnostic test for the detection of bacterial and viral infections.

A year on, the United States and most of the other countries affected by the Zika virus are better prepared to prevent outbreaks and control their spread. The proof is in the data.

Jason Pogue, PharmD, BCPS-ID, explains how ceftolozane-tazobactam differs from other beta-lactams for treating Pseudomonas infections.

Hanneke Schuitemaker, PhD, explains what makes Janssen’s new HIV-1 vaccine regimen unique.

In a new study published in the journal Vaccine, researchers examine the antibody response to the flu vaccine in pregnant women and their babies.

Milena McLaughlin, PharmD, MSc, explains ways to remain vigilant when it comes to drug shortages.

New HIV drugs, vaccine regulations in France, correlations between intestinal viruses & type 1 diabetes, the susceptibility of Florida mosquitoes to transmit chikungunya, and an evaluation of the risk of hepatitis B reactivation in veterans on direct-acting antiviral therapy make up our Top 5 articles for the week of July 30, 2017.

Elizabeth Phillips, MD, FRCPC, FRACP, addresses the misconceptions about penicillin allergies.

A new study reports that Escherichia coli (E. coli) bacteria are commandeering copper ions to strengthen bacteria levels in hard-to-treat urinary tract infections (UTIs).

Global health security impacts us all and without the Global Health Security Agenda (GHSA), we may see an increase in global public health crises.

The Centers for Disease Control and Prevention (CDC) is providing local agencies with a boost—in the form of $200 million—to improve surveillance, laboratory diagnostic capabilities, and outbreak response.

Alex Rinehart, PhD, Director, Global Prevention Strategy, ViiV Healthcare, explains what makes cabotegravir a unique medication for HIV.

In a 12-1 vote, the FDA’s Vaccines and Related Biological Products Advisory Committee supported the safety data of a new potential hepatitis B vaccine.

Some 90% of healthcare organizations represented in one study had experienced a data breach in the past 2 years alone.